About this Special Issue
Noncoding RNAs have emerged as potent regulators of gene expression in the nervous system. Many noncoding RNAs are responsive to drug and alcohol exposure and manipulation of noncoding RNAs may impact drug seeking behavior. However, the field of noncoding RNAs in substance use disorder (SUD) is still understudied and many noncoding RNAs have not been examined in SUD patients or models of drug exposure. This Special Issue will feature studies that investigate noncoding RNAs in drug and alcohol research to highlight the mechanisms of noncoding RNA regulation that are associated with SUD. Examples include: noncoding RNAs in drug seeking phenotypes; noncoding RNAs as biomarkers; noncoding RNAs in HIV/SUD; and drug-induced regulation of noncoding RNAs. Work performed in model organisms, preclinical models or clinical populations is welcomed.
For authors, please also review the journal's information regarding Author Guidelines and Article Processing Charges, or direct any questions to the Editorial Office: adar.office@frontierspartnerships.org.
Extended Abstract deadline: 1 December 2022
Manuscript deadline: 1 February 2023
Keywords: noncoding RNAs, drug and alcohol exposure, SUD, biomarkers, drug seeking phenotypes
